Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Blood|September 2, 2020
Results of a phase 2 trial of an oral CXCR4 antagonist, mavorixafor, for treatment of WHIM syndromeDavid C Dale, Frank Firkin, Audrey Anna Bolyard, et al.
The Journal of Experimental Medicine|May 28, 2017
Lymphoid differentiation of hematopoietic stem cells requires efficient Cxcr4 desensitizationChristelle Freitas, Monika Wittner, Julie Nguyen, et al.
Orphanet Journal of Rare Diseases|September 27, 2012
Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia RegistrySarah Beaussant Cohen, Odile Fenneteau, Emmanuel Plouvier, et al.
The Journal of Clinical Investigation|February 2, 2021
Combined immunodeficiency due to a mutation in the γ1 subunit of the coat protein I complexWayne Bainter, Craig D Platt, Seung-Yeol Park, et al.
Blood Advances|May 5, 2026
Safety and efficacy of allogeneic CD19-directed CAR-T therapy CTX110 in relapsed/refractory B-cell non-Hodgkin lymphomaJoseph P McGuirk, Armin Ghobadi, Carlos R Bachier, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2021
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug AdministrationAndrew Dj Pearson, Claudia Rossig, Crystal Mackall, et al.
Pageof 1